Vitamin d deficiency predicts poor clinical outcomes in heart failure patients undergoing cardiac resynchronization therapy

P. Perge, A. M. Boros, L. Gellér, I. Osztheimer, Sz Szilágyi, T. Tahin, A. Apor, K. V. Nagy, E. Zima, L. Molnár, B. Merkely, G. Széplaki

Research output: Contribution to journalArticle

Abstract

Background and Aims. Resynchronization therapy (CRT) improves mortality and induces reverse remodeling in heart failure (HF) patients with reduced ejection fraction and wide QRS. Nonetheless, some patients do not improve despite the optimal medical therapy and right indications for device implantation. Therefore, finding biomarkers suitable for identification of those patients is crucial. Vitamin D plays a classic hormonal role in the regulation of bone metabolism and also has physiological functions in wide range of nonskeletal tissues. Based on recent studies, low levels of vitamin D seem to directly contribute to pathogenesis and worsening of HF. We planned to assess the role of vitamin D levels on clinical outcomes of HF patients undergoing CRT. Methods and Results. We enrolled 136 HF patients undergoing CRT. Total plasma vitamin D levels were measured at baseline and 6 months later. Primary endpoint was 5-year all-cause mortality; secondary endpoint was lack of good clinical response, defined as less than 15% increase of left ventricular ejection fraction after six months. During follow-up, 58 patients reached the primary, and 45 patients reached the secondary endpoint. Vitamin D levels less than 24.13 ng/mL predicted 5-year mortality (p=0.045) and poor clinical response (p=0.03) after adjusting to all significant baseline predictors. Conclusion. Our study showed that vitamin D deficiency has a significant impact in heart failure patients; it is an independent predictor of lack of midterm clinical response and long-Term mortality in patients undergoing CRT. Therefore, monitoring vitamin D status of heart failure patients could be of clinical significance.

Original languageEnglish
Article number4145821
JournalDisease markers
Volume2019
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Cardiac resynchronization therapy
Avitaminosis
Cardiac Resynchronization Therapy
Vitamin D
Vitamins
Heart Failure
Cathode ray tubes
Mortality
Biomarkers
Metabolism
Vitamin D Deficiency
Bone
Tissue
Stroke Volume
Plasmas

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Vitamin d deficiency predicts poor clinical outcomes in heart failure patients undergoing cardiac resynchronization therapy. / Perge, P.; Boros, A. M.; Gellér, L.; Osztheimer, I.; Szilágyi, Sz; Tahin, T.; Apor, A.; Nagy, K. V.; Zima, E.; Molnár, L.; Merkely, B.; Széplaki, G.

In: Disease markers, Vol. 2019, 4145821, 01.01.2019.

Research output: Contribution to journalArticle

Perge, P. ; Boros, A. M. ; Gellér, L. ; Osztheimer, I. ; Szilágyi, Sz ; Tahin, T. ; Apor, A. ; Nagy, K. V. ; Zima, E. ; Molnár, L. ; Merkely, B. ; Széplaki, G. / Vitamin d deficiency predicts poor clinical outcomes in heart failure patients undergoing cardiac resynchronization therapy. In: Disease markers. 2019 ; Vol. 2019.
@article{3c15ce562a2b421884cdf9bdcf61e1b3,
title = "Vitamin d deficiency predicts poor clinical outcomes in heart failure patients undergoing cardiac resynchronization therapy",
abstract = "Background and Aims. Resynchronization therapy (CRT) improves mortality and induces reverse remodeling in heart failure (HF) patients with reduced ejection fraction and wide QRS. Nonetheless, some patients do not improve despite the optimal medical therapy and right indications for device implantation. Therefore, finding biomarkers suitable for identification of those patients is crucial. Vitamin D plays a classic hormonal role in the regulation of bone metabolism and also has physiological functions in wide range of nonskeletal tissues. Based on recent studies, low levels of vitamin D seem to directly contribute to pathogenesis and worsening of HF. We planned to assess the role of vitamin D levels on clinical outcomes of HF patients undergoing CRT. Methods and Results. We enrolled 136 HF patients undergoing CRT. Total plasma vitamin D levels were measured at baseline and 6 months later. Primary endpoint was 5-year all-cause mortality; secondary endpoint was lack of good clinical response, defined as less than 15{\%} increase of left ventricular ejection fraction after six months. During follow-up, 58 patients reached the primary, and 45 patients reached the secondary endpoint. Vitamin D levels less than 24.13 ng/mL predicted 5-year mortality (p=0.045) and poor clinical response (p=0.03) after adjusting to all significant baseline predictors. Conclusion. Our study showed that vitamin D deficiency has a significant impact in heart failure patients; it is an independent predictor of lack of midterm clinical response and long-Term mortality in patients undergoing CRT. Therefore, monitoring vitamin D status of heart failure patients could be of clinical significance.",
author = "P. Perge and Boros, {A. M.} and L. Gell{\'e}r and I. Osztheimer and Sz Szil{\'a}gyi and T. Tahin and A. Apor and Nagy, {K. V.} and E. Zima and L. Moln{\'a}r and B. Merkely and G. Sz{\'e}plaki",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/4145821",
language = "English",
volume = "2019",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",

}

TY - JOUR

T1 - Vitamin d deficiency predicts poor clinical outcomes in heart failure patients undergoing cardiac resynchronization therapy

AU - Perge, P.

AU - Boros, A. M.

AU - Gellér, L.

AU - Osztheimer, I.

AU - Szilágyi, Sz

AU - Tahin, T.

AU - Apor, A.

AU - Nagy, K. V.

AU - Zima, E.

AU - Molnár, L.

AU - Merkely, B.

AU - Széplaki, G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background and Aims. Resynchronization therapy (CRT) improves mortality and induces reverse remodeling in heart failure (HF) patients with reduced ejection fraction and wide QRS. Nonetheless, some patients do not improve despite the optimal medical therapy and right indications for device implantation. Therefore, finding biomarkers suitable for identification of those patients is crucial. Vitamin D plays a classic hormonal role in the regulation of bone metabolism and also has physiological functions in wide range of nonskeletal tissues. Based on recent studies, low levels of vitamin D seem to directly contribute to pathogenesis and worsening of HF. We planned to assess the role of vitamin D levels on clinical outcomes of HF patients undergoing CRT. Methods and Results. We enrolled 136 HF patients undergoing CRT. Total plasma vitamin D levels were measured at baseline and 6 months later. Primary endpoint was 5-year all-cause mortality; secondary endpoint was lack of good clinical response, defined as less than 15% increase of left ventricular ejection fraction after six months. During follow-up, 58 patients reached the primary, and 45 patients reached the secondary endpoint. Vitamin D levels less than 24.13 ng/mL predicted 5-year mortality (p=0.045) and poor clinical response (p=0.03) after adjusting to all significant baseline predictors. Conclusion. Our study showed that vitamin D deficiency has a significant impact in heart failure patients; it is an independent predictor of lack of midterm clinical response and long-Term mortality in patients undergoing CRT. Therefore, monitoring vitamin D status of heart failure patients could be of clinical significance.

AB - Background and Aims. Resynchronization therapy (CRT) improves mortality and induces reverse remodeling in heart failure (HF) patients with reduced ejection fraction and wide QRS. Nonetheless, some patients do not improve despite the optimal medical therapy and right indications for device implantation. Therefore, finding biomarkers suitable for identification of those patients is crucial. Vitamin D plays a classic hormonal role in the regulation of bone metabolism and also has physiological functions in wide range of nonskeletal tissues. Based on recent studies, low levels of vitamin D seem to directly contribute to pathogenesis and worsening of HF. We planned to assess the role of vitamin D levels on clinical outcomes of HF patients undergoing CRT. Methods and Results. We enrolled 136 HF patients undergoing CRT. Total plasma vitamin D levels were measured at baseline and 6 months later. Primary endpoint was 5-year all-cause mortality; secondary endpoint was lack of good clinical response, defined as less than 15% increase of left ventricular ejection fraction after six months. During follow-up, 58 patients reached the primary, and 45 patients reached the secondary endpoint. Vitamin D levels less than 24.13 ng/mL predicted 5-year mortality (p=0.045) and poor clinical response (p=0.03) after adjusting to all significant baseline predictors. Conclusion. Our study showed that vitamin D deficiency has a significant impact in heart failure patients; it is an independent predictor of lack of midterm clinical response and long-Term mortality in patients undergoing CRT. Therefore, monitoring vitamin D status of heart failure patients could be of clinical significance.

UR - http://www.scopus.com/inward/record.url?scp=85074291964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074291964&partnerID=8YFLogxK

U2 - 10.1155/2019/4145821

DO - 10.1155/2019/4145821

M3 - Article

C2 - 31737126

AN - SCOPUS:85074291964

VL - 2019

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

M1 - 4145821

ER -